Monthly Archives: March 2012

Pain affect in the absence of pain sensation: evidence of asomaesthesia after somatosensory cortex lesions in the rat.

Posted on March 3, 2012 by Maurice Preter MD

Pain. 2012 Feb 23. [Epub ahead of print]Pain affect in the absence of pain sensation: evidence of asomaesthesia after somatosensory cortex lesions in the rat.Uhelski ML, Davis MA, Fuchs PN.Source Department of Diagnostic and Biological Sciences, University of Minnesota Twin … Continue reading →

Posted in Affective Neuroscience, Psychiatry/Neurology | Tagged , |

Inflammation during fetal and neonatal life: Implications for neurologic and neuropsychiatric disease in children and adults.

Posted on March 3, 2012 by Maurice Preter MD

Ann Neurol. 2011 Sep 2. doi: 10.1002/ana.22620. [Epub ahead of print]Inflammation during fetal and neonatal life: Implications for neurologic and neuropsychiatric disease in children and adults.Hagberg H, Gressens P, Mallard C.Source Department of Obstetrics and Gynecology, Institute of Clinical Sciences, … Continue reading →

Posted in development, epigenetics | Tagged |

Psychosocial stress and cardiovascular risk : current opinion.

Posted on March 3, 2012 by Maurice Preter MD

Swiss Med Wkly. 2012 Jan 20;142:0. doi: 10.4414/smw.2012.13502.Psychosocial stress and cardiovascular risk : current opinion.von Känel R.Source Division of Psychosomatic Medicine, Department of General Internal Medicine, Inselspital, Bern University Hospital, and University of Bern, Switzerland. roland.vonkaenel@insel.chAbstract Cardiovascular disease (CVD) is … Continue reading →

Posted in epigenetics, Psychiatry/Neurology | Tagged , , |

The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.

Posted on March 3, 2012 by Maurice Preter MD

Nutr J. 2011 Oct 20;10:117. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. … Continue reading →

Posted in Aging, Health, metabolic, new treatments | Tagged , , |

Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.

Posted on March 3, 2012 by Maurice Preter MD

Neuropsychopharmacology. 2012 Jan;37(1):137-62. doi: 10.1038/npp.2011.205. Epub 2011 Sep 14.Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.Haroon E, Raison CL, Miller AH.Source Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.Abstract … Continue reading →

Posted in Psychiatry/Neurology |
Maurice Preter, MD

Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.